FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra

Sep 16, 2026 - 15:00
 0  0
THOUSAND OAKS, Calif., Sept. 14, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) approved an update to the Imdelltra (tarlatamab-dlle) Prescribing Information that substantially reduces...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0